|
End-of-day quote
Egyptian Exchange
2026-11-12
|
5-day change | 1st Jan Change | ||
| 335.00 EGP | +3.07% |
|
+19.22% | +234.26% |
| Market Cap | 16.75B 314M 284M 263M 237M 447M 29.56B 463M 3.16B 1.25B 15.79B 1.18B 1.15B 50.13B | P/E 2025 |
11.7x | P/E 2026 | 32x |
|---|---|---|---|---|---|
| Enterprise Value | 18.29B 342M 310M 287M 259M 488M 32.28B 505M 3.45B 1.37B 17.24B 1.28B 1.26B 54.73B | EV / Sales 2025 |
1.89x | EV / Sales 2026 | 4.56x |
| Free-Float |
20.38% | Yield 2025 |
4.1% | Yield 2026 | - |
| 1 day | +3.07% | ||
| 1 week | +19.22% | ||
| Current month | +18.37% | ||
| 1 month | +20.94% | ||
| 3 months | -18.30% | ||
| 6 months | +98.93% | ||
| Current year | +234.26% |
| 1 week | 290.07 |  | 338.5 |
| 1 month | 205 | | 338.5 |
| Current year | 87 | | 516.96 |
| 1 year | 87 | | 516.96 |
| 3 years | 41.3 | | 516.96 |
| 5 years | 24 | | 516.96 |
| 10 years | 8.7 | | 516.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Chairman | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.07% | +19.22% | +212.79% | +358.97% | 314M | |
| +1.26% | +6.61% | +40.79% | +136.32% | 1,286B | |
| +0.79% | +3.45% | +45.84% | +93.52% | 688B | |
| +0.20% | +1.28% | +26.97% | +113.70% | 521B | |
| -0.44% | +3.69% | +41.45% | +68.91% | 386B | |
| +0.55% | +0.70% | +59.02% | +44.62% | 364B | |
| -0.12% | +0.74% | +28.39% | +58.54% | 302B | |
| +0.37% | +0.37% | +3.33% | +37.27% | 287B | |
| -0.30% | +1.14% | +38.29% | +72.46% | 252B | |
| +0.08% | +0.71% | +34.44% | +124.95% | 208B | |
| Average | +0.55% | +3.50% | +53.13% | +110.92% | 429B | |
| Weighted average by Cap. | +0.54% | +3.26% | +37.71% | +96.52% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.29B 24.14M 21.88M 20.23M 18.26M 34.4M 2.28B 35.62M 243M 96.38M 1.22B 90.59M 88.67M 3.86B | 2.13B 39.95M 36.2M 33.48M 30.21M 56.93M 3.77B 58.94M 402M 159M 2.01B 150M 147M 6.39B |
| Net income | 126M 2.35M 2.13M 1.97M 1.78M 3.35M 222M 3.47M 23.7M 9.4M 119M 8.83M 8.64M 376M | 256M 4.8M 4.35M 4.02M 3.63M 6.84M 453M 7.08M 48.32M 19.16M 242M 18.01M 17.63M 767M |
| Net Debt | 967M 18.11M 16.41M 15.18M 13.69M 25.81M 1.71B 26.72M 182M 72.3M 912M 67.96M 66.51M 2.9B | 1.54B 28.77M 26.08M 24.12M 21.76M 41.01M 2.71B 42.45M 290M 115M 1.45B 108M 106M 4.6B |
Employees
-
Sector
Pharmaceuticals
Calendar
Nov. 25
Ex-dividend date - 0.5 EGP
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-12 | EGP 335.00 | +3.07% | 492,956 |
| 26-11-11 | EGP 325.01 | +6.21% | 682,321 |
| 26-11-10 | EGP 306.00 | +0.79% | 352,564 |
| 26-11-09 | EGP 303.61 | +5.42% | 848,099 |
| 26-11-08 | EGP 288.01 | +2.49% | 588,949 |
- Stock Market
- Stocks
- NIPH Stock
Select your edition
All financial news and data tailored to specific country editions
